A non-invasive treatment that uses high-intensity pulses of visible light to decrease inflammation and redness in rosacea, as well as hyperpigmentation from sun damage. Light-Based therapies like IPL, BBL and PDL show much promise for decreasing inflammation and redness in rosacea, as well as hyperpigmentation from sun damage GlowBEAM is a new advanced, powerful Light Therapy designed to brighten skin, calm erythema and treat sun damage of the hands, chest and face. More powerful than IPL and BBL, GlowBEAM Dye VL Pro technology can only be used under medical supervision. Best for age spots, red sun spots, freckles, brown spots and pigmentation of face, neck, chest and hands, Facial lines & wrinkles, Rosacea. rosy cheeks & redness, broken facial veins/telangiectasia, acne marks (Post-Inflammatory Hyperpigmentation/PIH and Post-Inflammatory Erythema/PIE) whilst improving acne. Photofacials like GlowBEAM can be safely started whilst on most acne therapies and may be more effective to improve acne resolution than those treatments on their own.
Downtime
Two to three days
Optimal No of Sessions for Best Results
A course of three sessions is usually required.
The Science
Almas Dye-VL Pro technology used in our GlowBEAM has a narrow band spectrum in the optimal range for haemoglobin absorption, making it highly effective in targeting vascular lesions and rosacea. High absorption in melanin makes it also effective in removing sunspots (lentigos) and pigmentation. The new and advanced Dye-VL PRO cooled applicator is highly powerful and effective with a focused 1 cm2 spot size, high peak power and intense cooling, it provides excellent clinical results. GlowBEAM can be used over the entire body with its easy glide mechanism -the ultimate in whole body photorejuvenation.
Images are for illustrative purposes only – we do not sell services online. All images sourced from Pinterest.
Premium laser, health and skin treatments in Cape Town. Overseen by Dr Cardoso, the top-rated family doctor in Cape Town, and trusted by international patients from the UK, US, EU and around the world.